EuroPRevent 2013

18 - 20 April 2013, Rome - Italy

Session Details

Poster session 3: Poster Session 3
Fri 19 Apr 14:00 - 18:00 Other risk factors (Prevention & Epidemiology) Poster Session Poster Area - Poster Zone

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
14:00P437Group 1 hosted byDietrich Cl GULBA (Oberhausen, DE)
14:00P438Risk factors for cardiovascular disease in the general population of Ghent, Belgium: awareness and treatment for hypertension and/or hypercholesterolemiaKoen VAN HERCK (Ghent, BE)
14:00P439Type 1 plasminogen activator inhibitor (PAI-1) and risk of acute coronary syndrome in the european prospective investigation into cancer (EPIC)-Italy cohort.Licia IACOVIELLO (Campobasso, IT)
14:00P440Chest radiotherapy as cardiovascular risk factor: the need of screening of asymptomatic patients.To Be Announced
14:00P441Sleep quality and sleep duration- potentially modifiable risk factors for coronary artery disease?Monika SHARMA (New Delhi, IN)
14:00P442Association of leukocyte telomere length with left ventricular diastolic dysfunction in the aging heart.Dariga AKASHEVA (Moscow, RU)
14:00P443Association of D-dimer with cardiovascular disease and all-cause mortality in a healthy population: findings from the MOLI-SANI studyAugusto Filippo DI CASTELNUOVO (Campobasso, IT)
14:00P444Dietary electrolytes and risk of ischemic strokeIvonne SLUIJS (Utrecht, NL)
14:00P445Statin therapy in patients with nonalcoholic fatty liver disease and cardiovascular riskRaia IVANOVA (Sofia, BG)
14:00P446Influenza infection can trigger cardiovascular events and is an emerging target for preventing cardiovascular events Mohammad MADJID (Houston, US)
14:00P447Case fatality of myocardial infarction among shift workersTo Be Announced
14:00P448Group 2 hosted byEva PRESCOTT (Copenhagen, DK)
14:00P449Adhesion to regular physical activity : the short- term role of the accelerometer .Gabriele MASCHERINI (Florence, IT)
14:00P450Cardiovascular and metabolic effects of hormone replacement therapy containing drospirenone in postmenopausal women with climacteric syndrome.Victoria MYCHKA (Moscow, RU)
14:00P451 Prognostic stratification by conventional echocardiography of patients with aortic stenosis: the CAIMAN ECHO scoreTo Be Announced
14:00P452Endothelial dysfunction parameters as the predictors for patients with acute coronary syndrome without ST-segment elevationEvgeniya SHMIDT (Kemerovo, RU)
14:00P453Effect of 13 weeks lifestyle intervention in employees with cardiovascular risk factors: a pilot studyJoerg KITTEL (Ennepetal, DE)
14:00P454Impact of coronary artery calcium screening on life style modification and drug therapy adherence among patients without known coronary artery diseaseAtanas ANGELOV (Varna, BG)
14:00P455Effects of atorvastatin and rosuvastatin on renal function: a meta-analysisGianluigi SAVARESE (Naples, IT)
14:00P456Sufficient hydration is associated with lower likelihood of ischemic stroke presence: a case-control studyDemosthenes B PANAGIOTAKOS (Athens, GR)
14:00P457Prevention of hospital infection following cardiac surgery by identification of independent risk factorsBogoljub MIHAJLOVIC (Sremska Kamenica, RS)
14:00P458Genetic determinants of metabolic syndrome in russian populationAlexandra KONRADI (St. Petersburg, RU)
14:00P459Group 3 hosted byNathan WONG (Irvine, US)
14:00P460Implication of interleukin-6 gene polymorphism in susceptibility to acute myocardial infarctionTo Be Announced
14:00P461Plasma dimethylglycine is associated with all-cause mortality in patients with coronary heart disease.Gard Frodahl Tveitevaag SVINGEN (Bergen, NO)
14:00P462Do changes of serum uric acid levels predict cardiovascular events? A meta-regression analysis of 11 randomized trialsGianluigi SAVARESE (Naples, IT)
14:00P463Promoting physical activity for cardiovascular disease prevention in primary careMargaret CUPPLES (Belfast, GB)
14:00P464Association of sPLA2-IIA gene SNPs, mass and activity of secretory PLA2-IIa and the coronary atherosclerosis.Tatyana PAVLUNINA (Moscow, RU)
14:00P465Cardiovascular prevention in young patients.Belen DIAZ ANTON (Madrid, ES)
14:00P466Effects of antiretroviral treatment on endothelial dysfunction and regeneration in HIV-positive patients:1 year of follow-up.Francesca CESARI (Florence, IT)
14:00P467Risk factors for coronary heart disease in women with chronic kidney disease of glomerular originKhrystyna SEMEGEN-BODAK (Lviv, UA)
14:00P468Association between metabolic syndrome and hyperhomocysteinemia in patients with acute coronary syndromeBelen RUBIO ALONSO (Madrid, ES)
14:00P469Preclinical atherosclerosis and Mediterranean Diet in pre-menopausal womenAnna Vittoria MATTIOLI (Modena, IT)
14:00P470Group 4 hosted byPeter B MATHES (Feldafing, DE)
14:00P471Differences in arterial stiffness between ischemic stroke subtypes.Peter WOHLFAHRT (Prague, CZ)
14:00P472Worker healthy effect in cardiovascular disease prospective cohorts. Does it still matter? Comparing survival curves of northern Italian population-based and factory-based cohortsTo Be Announced
14:00P473Cabergoline use and risk of fibrosis and insufficiency of cardiac valves : a meta-analysis of 12 observational studies.Carmelina ARIANO (Aversa, IT)
14:00P474Development of a nanocomposite based small-diameter vessel from bone marrow derived mesenchymal stem cells (hBMSCs) To Be Announced
14:00P475The issue whether it is feasible that progression of non-rheumatic aortic valve stenosis is retarded using statins: a meta-analysis.Carmelina ARIANO (Aversa, IT)
14:00P476Sudden death in patients with hypertrophic cardiomyopathyNatalia KRYLOVA (Moscow, RU)
14:00P477The first 3 years of a New Zealand, nurse led, out patient clinic for patients following heart valve surgery.To Be Announced
14:00P478Effects of consumption a bread contains agave or chicory inulin on lipids and blood pressure in patients with cardiovascular risk factorsTo Be Announced
14:00P479A big problem for a big country; the health and economic burden of cardiovascular diseases in RussiaTo Be Announced
14:00P480Prevention of tromboembolism in patients with atrial fibrillation: retrospective study of hospitalized patients.Elena CHUMAK (Arkhangelsk, RU)
14:00P481Group 5 hosted byDavid GOFF (Aurora, US)
14:00P482Influence of prehospital and in-hospital cardiovascular therapy use on short-term and long-term prognosis in patients with acute myocardial infarction.Sergey MARTSEVICH (Moscow, RU)
14:00P483Cardiopulmonary and non-invasive hemodynamic responses to exercise predict outcomes in heart failureJonathan MYERS (Palo Alto, US)
14:00P484Cardiopulmonary exercise test predicts sustained ventricular arrhythmias in chronic heart failure.Michele CORREALE (Foggia, IT)
14:00P485Atorvastatin improves prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry.Michele CORREALE (Foggia, IT)
14:00P486Improvement in the quality of life in patients followed in a heart failure unitMiguel Angel RAMIREZ-MARRERO (Malaga, ES)
14:00P487Prognostic impact of hyperglycemia at admission and high level of glycated hemoglobin in diabetic patients hospitalized for acute heart failure.Sonia HAMDI (Monastir, TN)
14:00P488Tissue Doppler Time Intervals predict the occurrence of re-hospitalization in chronic heart failureCarmen GRECO (Foggia, IT)
14:00P489Globalization of clinical trials and harmonizing gender and regions representation: differences between female patients with stable Chronic Heart Failure from Germany and former Yugoslavia - CIBIS ELDSvetlana APOSTOLOVIC (Nis, RS)
14:00P490Fibrosis markers and CRIM-1 increase in Chronic Heart Failure of increasing severity;Ermanno ELEUTERI (Veruno, IT)
14:00P491Preventing cardiotoxicity in breast cancer patients treated with trastuzumab in adjuvant settingAndra Iulia SUCEVEANU (Constanta, RO)
14:00P492Group 6 hosted byJulian HALCOX (Cardiff, GB)
14:00P493Impact of elevated uric acid on left ventricular remodeling and endothelial dysfunction in chronic heart failure (CHF) patientsSlavica RADOVANOVIC (Belgrade, RS)
14:00P494A diagnostic screening model for recognition of heart failure in patients with type 2 diabetesLeandra BOONMAN-DE WINTER (Etten-Leur, NL)
14:00P495Soluble RAGE levels in Chronic Heart Failure and its correlation to Left Ventricular Ejection function To Be Announced
14:00P496Apical rocking is a marker of left ventricle dyssynchrony and elevated filling pressures in septal asymmetric hypertrophic cardiomyopathy.Carla SOUSA (Porto, PT)
14:00P497RAGE gene polymorphism in Heart Failure patients with and without angiographic evidence of significant coronary atherosclerosis To Be Announced
14:00P498Additive prognostic value of lymphocyte G-protein coupled receptor kinase 2 on plasma N-Terminal proBNP in patients with heart failureGennaro PAGANO (Napoli, IT)
14:00P499Effect of milrinone on short term outcome of patients with myocardial dysfunction undergoing Off-Pump Coronary Artery Bypass graft: a randomized clinical trialSeyed Mohammad Yousof MOSTAFAVI POUR MANSHADI (Yazd, IR)
14:00P500Multiparametric evaluation of pulmonary congestion in patients with heart failureGabriella Guglielmina Barbara MALFATTO (Milano, IT)
14:00P501Impact of diabetes mellitus on iodine-123 meta-iodobenzylguanidine (I123MIBG) cardiac uptake in patients with heart failureStefania PAOLILLO (Torre Del Greco, IT)
14:00P502Left ventricular diastolic function is strongly correlated with active emptying of the left atrium: a novel analysis using three-dimensional echocardiographyTo Be Announced
14:00P503Group 7 hosted byUwe NIXDORFF (Duesseldorf, DE)
14:00P504Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.Gennaro PAGANO (Napoli, IT)
14:00P505Inequalities in heart failure in older age: prospective associations between socioeconomic measures and heart failure from a 10-year follow-up studySheena RAMSAY (London, GB)
14:00P506Patterns of smoking in Poland. Results of the NATPOL 2011 surveyTomasz ZDROJEWSKI (Sopot, PL)
14:00P507Smoking cessation: NRT or educated volition ? Best, both of them.Radu M NEGOESCU (Bucharest, RO)
14:00P508Effect of non-smoking tobacco on endothelial function in healthy menEli-Anne SKAUG (Trondheim, NO)
14:00P509Are Spanish cardiologists engaged in smoking cessation interventions?Regina DALMAU (Madrid, ES)
14:00P510Smoking cessation advisory intervention in patients with cardiovascular diseaseIoannis A VOGIATZIS (Thessaloniki, GR)
14:00P511The lack of concern about the toxic effect of tobacco smoke is related to the degree of addictionMaria De Las Nieves MONTORO LOPEZ (Madrid, ES)
14:00P512Weight gain in patients who stop smoking after an acute coronary syndrome: an analysis from a randomised clinical trial in the NetherlandsMadelon MINNEBOO (Amsterdam, NL)
14:00P513Combined association of physical activity, ischaemic heart disease and comorbid depression on mortality risk in the elderly: The HUNT StudyLinda ERNSTSEN (Trondheim, NO)
14:00P514Group 8 hosted byHaruki ITOH (Tokyo, JP)
14:00P515Preserved cognitive function seems to be parallel with good aortic distensibility in elderly individuals: the Ikaria StudyChristos PITSAVOS (Chalandri (Athens), GR)
14:00P516Financial status satisfaction is associated with lower likelihood of non-fatal acute coronary syndrome or ischemic stroke presence: a case/case-control studyDemosthenes B PANAGIOTAKOS (Athens, GR)
14:00P517Physical functioning and cardiovascular disease incidence in Poland. The HAPIEE Study.Agnieszka DORYNSKA (Krakow, PL)
14:00P518Perceived control as a determinant of cardiovascular disease mortality in Poland. The HAPIEE Study.Magdalena KOZELA (Krakow, PL)
14:00P519One-year results of the randomized, controlled Short-Term Psychotherapy IN Acute Myocardial Infarction (STEP-IN-AMI) TrialTo Be Announced
14:00P520Depression, subclinical inflammation and annual prognosis in ST-segment elevation myocardial infarction depending on type 2 diabetes mellitus historyNataliya LEBEDEVA (Kemerovo, RU)
14:00P521A mixed methods study investigating readmission, symptom attribution and psychological health in primary percutaneous coronary intervention patientsHeather ILES-SMITH (Warrington, GB)
14:00P522What was the efficiency of the prevention in the last 14 years?Jean VALTY (Paris, FR)
14:00P523The relationship between socioeconomic factors and cardiovascular mortality in Western Siberia, Russia: a prospective cohort study.Georgiy PUSHKAREV (Tyumen, RU)
14:00P524Gender differences in quality of life five years after myocardial revascularizationMarija ZDRAVKOVIC (Belgrade, RS)
14:00P525Group 9 hosted byJohan DE SUTTER (Gent, BE)
14:00P526Risk perception of stroke in atrial fibrillation patients does not correlate with clinical stroke riskJane SKOV (Esbjerg, DK)
14:00P527Effect of individualized weight-loss programmes on adiponectin level in patients with abdominal obesity.Aelita BEREZINA (Saint Petersburg, RU)
14:00P52812-week nordic walking training program improves sexual life of women with metabolic syndrome.Sylwia SKORUPSKA (Warsaw, PL)
14:00P529Predictors of non sustained ventricular tachycardia in patients during cardiovascular rehabilitation after myocardial infarction treated with primary coronary intervention Slavica STEVOVIC (Beograd, RS)
14:00P530Betaxolol versus metoprolol for prevention of postoperative atrial fibrillation during cardiac rehabilitation (CR) in coronary surgery Luminita ILIUTA (Bucharest, RO)
14:00P531Risk stratification with ventricular dysfunction after and acute coronary syndrome.Fernando DE TORRES ALBA (Madrid, ES)
14:00P532Prediction model for frequent ventricular ectopy during exercise testing in patients with heart disease.Hermes ILARRAZA-LOMELI (Mexico City, MX)
14:00P533Predictors of blood pressure control in an integrated preventive ambulatory cardiology center in RomaniaPall KIKELI (Targu-Mures, RO)
14:00P534Effects of transcranial bright light treatment on cardiovascular autonomic regulationMikko TULPPO (Oulu, FI)
14:00P535Heated pool exercise training reduces office blood pressure in patients with resistant hypertensionGuilherme Veiga GUIMARAES (Sao Paulo, BR)
14:00P536Group 10 hosted bySven MOEBIUS-WINKLER (Weissenfels, DE)
14:00P537The impact of whole body cryotherapy in patients with hypertensionTo Be Announced
14:00P538Prevalence and clinical presentation of lower extremities peripheral arterial disease among 1,506 patients admitted to cardiac rehabilitation programmes in Italy: the THINKPAD registry.Marco AMBROSETTI (Cunardo, IT)
14:00P539The effect of physical training on arterial stiffness and central blood pressure.Mircea IURCIUC (Timisoara, RO)
14:00P540The benefits of combined Unfractioned Heparin and Clopidogrel in not reperfused patients with ST-elevation Myocardial Infarction.Erjon AGUSHI (Bologna, IT)
14:00P541Ursodeoxycholic acid in the management of dyslipidaemia in postpreeclamptic breastfeeding women: a randomized, case-control study.Ilshat GAISIN (Izhevsk, RU)
14:00P542Impact of national reimbursement guidelines for statins on lipid target attainment, results from the belgian ICARUS study.Johan DE SUTTER (Gent, BE)
14:00P543Predictors of lipid regulation after Percutaneous Coronary InterventionMarina LICINA (Belgrade, RS)
14:00P544Outcome of cardiac rehabilitation (CR) in transcatheter aortic valve implantation patients (TAVI): comparison with aortic valve replacement (AVR) and predictors of mortalityFranco TARRO GENTA (Turin, IT)
14:00P545Prognostic value of cardiac rehabilitation (CR) in patients with aortic stenosis and left ventricular systolic dysfunction undergoing aortic valve replacement (AVR)Luminita ILIUTA (Bucharest, RO)
14:00P546Beneficial effects of efonidipine, Calcium Channel Blocker, on exercise intolerance, renal function, and arterial stiffness in patients with Acute Myocardial InfarctionToshio NAKA (Nishimomiya, JP)
14:00P547Group 11 hosted byGrethe S TELL (Bergen, NO)
14:00P548Importance of left ventricular diastolic function at rest for exercise tolerance in patients after myocardial infarctionTo Be Announced
14:00P549The physioterapic treatment pre and post operatory in cardiac surgery: better outcome and complicance reduction or only psycologic progress?Maria Teresa PEYER (Caserta, IT)
14:00P550Benefits of Exercise Ttraining in Type2 diabetic patients with heart failure with preserved ejection fractionAniello ASCIONE (Naples, IT)
14:00P551Determinants of structural carotid artery wall changes in hypertensive diabetic patientsOlga KOSHELSKAYA (Tomsk, RU)
14:00P552Lipids and inflammatory markers in patients with stable angina and type 2 diabetes.Liudmila GAPON (Tyumen, RU)
14:00P553Impaired pancreatic beta cell function may attenuate exercise training effects by inhibiting increased heart rate reserve in prediabetic patients with myocardial infarctionKazuto OMIYA (Yokohama, JP)
14:00P554Relationship of fatigue with emotional state and heart rate variability in coronary artery disease patients admitted for rehabilitation programJulija BROZAITIENE (Palanga, LT)
14:00P555Endothelial function and insulin resistance: the role of cardiac rehabilitationNicola RUSSO (Padova, IT)
14:00P556Heart Rate Reserve and Cognitive ImpairmentEhud GOLDHAMMER (Haifa, IL)
14:00P557Exhaustion,depression, fatigue and coronary artery disease in womenTo Be Announced
14:00P558Group 12 hosted byAndreas OBERBACH (Leipzig, DE)
14:00P559Do psychosocial interventions decrease morbidity or mortality in coronary disease patients?To Be Announced
14:00P560Changes in illness beliefs are associated with improved outcomes in cardiac rehabilition - even in patients with type D personalityTo Be Announced
14:00P561Improved cardiac function after football training in type 2 diabetic menJakob SCHMIDT (Vaerloese, DK)
14:00P562Comparison of the myocardial stiffness of the left ventricle between elite athletes and the general population.Study with the use of tissue Doppler imagingKyriakos YIANGOU (Nicosia, CY)
14:00P563Diastolic function during exercise in athletes.Tea MONK-HANSEN (Koebenhavn, DK)
14:00P564The peculiarity of the rest electrocardiogramms in young elite athletes Leonid MAKAROV (Moscow, RU)
14:00P565Right ventricle volume in endurance and strength athletes measured with cardiac magnetic resonance and its correlation with tricuspid annulus displacement.To Be Announced
14:00P566Lowering of blood lipids by ultra endurance exercise in master athletes.Nick MATTSSON (Rodovre, DK)
14:00P567Cardiac safety at norwegian fitness facilities.Anne Kristine ANSTENSRUD (Oslo, NO)
14:00P568The use of tissue doppler imaging in differential diagnosis of the pathological from non-pathological left ventricular hypertrophy.Comparison between elite athletes and mildly hypertensive subjectsKyriakos YIANGOU (Nicosia, CY)
14:00P569Group 13 hosted byTrine KARLSEN (Trondheim, NO)
14:00P570Pathological findings in electrocardiographic and echocardiographic examinations in top athletes.Klaus-Peter MELLWIG (Bad Oeynhausen, DE)
14:00P571Early left ventricle remodeling in the youngest competitive footballers - what should we expect ?Marija ZDRAVKOVIC (Belgrade, RS)
14:00P572Effects of exercise training on autonomic function in breast cancer survivors. A DIANA-5 sub-study.Luigi MARESCA (Naples, IT)
14:00P573Effects of exercise training on anthropometric measures, cardiovascular capacity and vascular endothelial function in breast cancer survivors: a DIANA-5 sub-study.Alessandra VITELLI (Naples, IT)
14:00P574Effects on blood pressure and cardiorespiratory condition of an 8-week exercise programme of differing intensities in hypertensive patients: pilot studySara MALDONADO-MARTIN (Vitoria-Gasteiz, ES)